| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.22 | 7e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |